WERNERS PROTEIN BIOCHEMISTRY AND RIBOSOMAL DNA IN AGING

WERNERS 蛋白质生物化学和衰老过程中的核糖体 DNA

基本信息

  • 批准号:
    6168646
  • 负责人:
  • 金额:
    $ 10.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-01 至 2002-08-31
  • 项目状态:
    已结题

项目摘要

The candidate is M.D./Ph.D. who will have completed the clinical requirements of his residency in clinical pathology at Brigham and Women's Hospital prior to the proposed start date. He is committed to a career as a biomedical researcher in academic medicine, and has a particular interest in the biology of senescence. He has worked previously in the fields of molecular biology, the biochemistry of transcription and Drosophila developmental biology, and now wishes to learn more about experimental approaches to the study of aging. He also wishes to further develop the skills he will need to become an independent investigator. The proposed research will be carried out primarily in the laboratory of Dr. Leonard Guarente at M.I.T, who has engaged in detailed genetic and molecular investigations of aging in yeast for five years, and has expanded into studies in mouse and humans in the past two. Dr. Jeanne Wei, of the Harvard Division on Aging, will comentor the candidate, providing expertise on studies of aging in humans. The candidate will also participate in the regular activities of the Division on Aging. The candidate proposes two main investigations. First, to characterize the biochemical activities of the protein that is mutated in Werner's syndrome (WRN). The probable helicase activity of WRN will be defined and functional interactions with other proteins, including single stranded DNA binding proteins and topoisomerases, will be examined. Attempts will be made to define direct roles of WRN in simple recombination and transcription systems. The second part of the proposal is to examine the role of changes of ribosomal DNA (rDNA) metabolism in Werner's syndrome and in natural aging in humans and mice. Age-related changes in rDNA quantity, structure, and transcription in humans and mouse models will be examined. Finally, attempts will be made to determine the functional significance of these changes.
候选人是医学博士。谁将完成临床测试

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

F. Brad Johnson其他文献

Connections between cell senescence, chromatin, and neurodegeneration
  • DOI:
    10.1016/j.exger.2015.01.011
  • 发表时间:
    2015-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Qijun Chen;Elizabeth P. Crowe;Terra Kuhn;Jay E. Johnson;Brian D. Gregory;Gregory Donahue;Nancy M. Bonini;Shelley L. Berger;Chris Sell;Claudio Torres;F. Brad Johnson
  • 通讯作者:
    F. Brad Johnson

F. Brad Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('F. Brad Johnson', 18)}}的其他基金

IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA
先天性角化不良新治疗方法的鉴定和临床前评估
  • 批准号:
    10444915
  • 财政年份:
    2019
  • 资助金额:
    $ 10.11万
  • 项目类别:
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA
先天性角化不良新治疗方法的鉴定和临床前评估
  • 批准号:
    10210298
  • 财政年份:
    2019
  • 资助金额:
    $ 10.11万
  • 项目类别:
EPIGENETIC REGULATION OF SENESCENCE IN YEAST TELOMERASE MUTANTS
酵母端粒酶突变体衰老的表观遗传调控
  • 批准号:
    7488201
  • 财政年份:
    2008
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintainance by werner syndrome family proteins
维尔纳综合征家族蛋白维持端粒
  • 批准号:
    7915563
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintenance by Werner syndrome family proteins.
维尔纳综合征家族蛋白维持端粒。
  • 批准号:
    6891429
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintainance by werner syndrome family proteins
维尔纳综合征家族蛋白维持端粒
  • 批准号:
    8101042
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintenance by Werner syndrome family proteins.
维尔纳综合征家族蛋白维持端粒。
  • 批准号:
    7054775
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintenance by Werner syndrome family proteins.
维尔纳综合征家族蛋白维持端粒。
  • 批准号:
    7415158
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintenance by Werner syndrome family proteins.
维尔纳综合征家族蛋白维持端粒。
  • 批准号:
    7489213
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
Telomere maintenance by Werner syndrome family proteins.
维尔纳综合征家族蛋白维持端粒。
  • 批准号:
    7217951
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:

相似海外基金

Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10296437
  • 财政年份:
    2021
  • 资助金额:
    $ 10.11万
  • 项目类别:
Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10473793
  • 财政年份:
    2021
  • 资助金额:
    $ 10.11万
  • 项目类别:
Structural and mechanistic analysis of type II DNA topoisomerases
II 型 DNA 拓扑异构酶的结构和机制分析
  • 批准号:
    2059935
  • 财政年份:
    2018
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Studentship
Conference: 2016 Gordon Research Seminar on DNA Topoisomerases to be held at Sunday River in Newry, ME on August 6-7, 2016
会议:2016 年戈登 DNA 拓扑异构酶研究研讨会将于 2016 年 8 月 6 日至 7 日在缅因州纽里的 Sunday River 举行
  • 批准号:
    1643077
  • 财政年份:
    2016
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Standard Grant
2014 DNA Topoisomerases in Biology and Medicine Gordon Research Conference
2014 DNA 拓扑异构酶在生物学和医学戈登研究会议
  • 批准号:
    8714782
  • 财政年份:
    2014
  • 资助金额:
    $ 10.11万
  • 项目类别:
Biochemical Analyses of Type II DNA Topoisomerases
II 型 DNA 拓扑异构酶的生化分析
  • 批准号:
    7909236
  • 财政年份:
    2009
  • 资助金额:
    $ 10.11万
  • 项目类别:
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6976458
  • 财政年份:
    2004
  • 资助金额:
    $ 10.11万
  • 项目类别:
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6470650
  • 财政年份:
    2001
  • 资助金额:
    $ 10.11万
  • 项目类别:
DNA Topoisomerases and DNA Topology in E. coli
大肠杆菌中的 DNA 拓扑异构酶和 DNA 拓扑
  • 批准号:
    0090880
  • 财政年份:
    2001
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Continuing Grant
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6327943
  • 财政年份:
    2000
  • 资助金额:
    $ 10.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了